SFX by Ex Libris Inc.

Title:	Activating mutations in ALK provide a therapeutic target in neuroblastoma
Source:	Nature [0028-0836] George, R E yr:2008

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Sanda, T. "Transcription factors as therapeutic targets in lymphoid malignancies." International reviews of immunology 26.5-6 (2007): 305-332.
description	2.	Ogawa, Y. "Oncogenic mutations of ALK kinase in neuroblastoma." Nature 455.7215 (2008): 971-4.
description	3.	Mossé, Andrew M. "Identification of ALK as a major familial neuroblastoma predisposition gene." Nature 455.7215 (2008): 930-935.
description	4.	Hagan, N. "Dissecting the protein-RNA and RNA-RNA interactions in the nucleocapsid-mediated dimerization and isomerization of HIV-1 stemloop 1." Journal of molecular biology 365.2 (2007): 396-410.
description	5.	Kaihatsu, K. "Extending recognition by peptide nucleic acids (PNAs): Binding to duplex DNA and inhibition of transcription by tail-clamp PNA-Peptide conjugates." Biochemistry 42.47 (2003): 13996-14003.
description	6.	Janoueix-Lerosey, I. "Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma." Nature 455.7215 (2008): 967-970.
description	7.	Spieker, N. "The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32." Genomics 71.2 (2001): 214-21.
description	8.	Look, Jennifer P. "Emi1 Maintains Genomic Integrity during Zebrafish Embryogenesis and Cooperates with p53 in Tumor Suppression." Molecular and cellular biology 29.21 (2009): 5911-5922.
description	9.	Hajime Yamauchi Yuhei Hotta Morichika Konishi Ayum, H. "Fgf21 is essential for haematopoiesis in zebrafish." EMBO reports 7.6: 649-654.
description	10.	Koch, U. "Notch and cancer: a double-edged sword." Cellular and molecular life sciences 64.21 (2007): 2746-2762.
description	11.	Okamoto, T. "NF-kappa B signaling and carcinogenesis." Current pharmaceutical design 13.5 (2007): 447-62.
description	12.	Caron, H. "Neuroblastoma: biology, prognosis, and treatment." The Pediatric clinics of North America 55.1 (2008): 97-120.
description	13.	MacBeath, Jordan A B. "A quantitative protein interaction network for the ErbB receptors using protein microarrays." Nature 439.7073 (2005): 168-74.
description	14.	Longo, Gian Paolo P. "Familial neuroblastoma: a complex heritable disease." Cancer letters 197.1-2 (2003): 41-5.
description	15.	Castleberry, Gregory K P. "Changing trends of research and treatment in infant neuroblastoma." Pediatric blood & cancer 49.7, Suppl. S (2008): 1060-5.
description	16.	Futreal, P Andrew A. "A census of human cancer genes." Nature reviews. Cancer 4.3 (2004): 177-183.
description	17.	Turner, K. "Noncovalent Probes for the Investigation of Structure and Dynamics of Protein-Nucleic Acid Assemblies: The Case of NC-Mediated Dimerization of Genomic RNA in HIV-1." Biopolymers 91.4 (2009): 283-296.
description	18.	Bentin, T. "Combined triplex/duplex invasion of double-stranded DNA by "tail-clamp" peptide nucleic acid." Biochemistry 42.47 (2003): 13987-13995.
description	19.	Popenda, L. "Bulged adenosine influence on the RNA duplex conformation in solution." Biochemistry 47.18 (2008): 5059-5067.
description	20.	Yu, E. "Direct Probing of RNA Structures and RNA-Protein Interactions in the HIV-1 Packaging Signal by Chemical Modification and Electrospray Ionization Fourier Transform Mass Spectrometry." Journal of molecular biology 330.2 (2003): 211-23.